Ainos Inc AIMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment
-
Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract
-
Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence
-
Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework
-
VASRO Research Highlights Ainos' New Order, Semiconductor Commercial Momentum and 1 Billion+ Chemical Dataset
-
Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing
-
Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era
-
Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management
Trading Information
- Previous Close Price
- $0.96
- Day Range
- $0.92–0.95
- 52-Week Range
- $0.95–4.44
- Bid/Ask
- $0.87 / $0.95
- Shares Outstanding
- 7.38M
- Market Cap
- $6.87M
- Volume/Avg
- 2,189 / 187,054
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 460.16
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
- Stock Style Box
- Small Value
- Total Number of Employees
- 41
- Website
- https://www.ainos.com
Valuation
|
Metric
|
AIMD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.43 |
Price/Sales | 460.16 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AIMD
|
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.13 |
Interest Coverage | −18.79 |
Quick Ratio
AIMD
Profitability
|
Metric
|
AIMD
|
|---|---|
Return on Assets (Normalized) | −57.69% |
Return on Equity (Normalized) | −165.54% |
Return on Invested Capital (Normalized) | −60.88% |
Return on Assets
AIMD
Scientific & Technical Instruments Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Keyence Corp
KYCCF
| — | LOCK|vK | $123B | |||
| Keysight Technologies Inc
KEYS
| LOCK|P<z^sc | LOCK|QLl | $61B | |||
| Garmin Ltd
GRMN
| LOCK|vzZvr? | LOCK|?V!&! | $54B | |||
| Coherent Corp
COHR
| — | LOCK|G?!# | $52B | |||
| Teledyne Technologies Inc
TDY
| — | LOCK|&?>> | $28B | |||
| Hexagon AB ADR
HXGBY
| — | LOCK|#P> | $28B | |||
| Hexagon AB Class B
HXGBF
| — | LOCK|@$? | $28B | |||
| Sensata Technologies Holding PLC
ST
| LOCK|bDc&WM | LOCK|&&! | $6B | |||
| Vontier Corp Ordinary Shares
VNT
| LOCK|q!>N#P | LOCK|X%%MB | $4B | |||
| Badger Meter Inc
BMI
| LOCK|@lR^>$< | LOCK|^&#n | $4B |
United States